RE:RE:RE:Thanks Tomoldposty2 wrote: Heres a conspiracy theory from someone who knows little about the pharma or medical industries in general. But what if a large multinational is interested in EDT but is not in love the no. of shares issued, they make a few inquiries, have a few lattes with management and hatch a plan. They conspire to push the share price down, fake no interest in the company, meanwhile the company agrees not to self promote in anyway giving the appearance that the company has not accomplished a single thing the market loses interest and can only see a downside.Then BOOM here comes this unknown multinational with a lowball b.s. rescue bid, shareholders happy to get out with their skin still on, multinational steals the company, current top brass and management get cushy high paying jobs with loads of stock options and all is right in the world of high finance CRAZY RIGHT? BUT WHO KNOWS... all in fun.
Well done oldposty
Perhaps not as far fetched a theory as one might think
Here's how I might hone your theory...
1. We already know there is a large multinational that is very interested
2. the no. of shares o/s is irrelevent. It's all about market cap compared to the PV of a future cashflows X probability of success.
3. Interim data could greatly de-risk any pre FDA approval acquisition.
4. I don't think "top brass" is too interested in cushy jobs at eh multi-national